• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

F.D.A. Approves New Nasal Spray for Migraines

The New York Times – Business:

Pfizer’s treatment applies an approach that is different from some other products, which doctors say may make it safer for people at risk of heart attacks or stroke.

Christina Jewett
Author: Christina Jewett

This post first appeared in The New York Times – Business. Read the original article.

Written by

Christina Jewett

in

Drugs (Pharmaceuticals), Food and Drug Administration, Lancet Neurology, The (Journal), Migraine Headaches, Nerves and Nervous System, Pfizer Inc
←RuPaul Shreds ‘Stunt Queen’ Politicians Pushing To Ban Drag Shows In Fiery Video
Michael Tilson Thomas Revels in the Present With the New York Phil→

More posts

  • 11 Actors Who Accused Their Co-Stars Of Doing Horrible, Horrible, Horrible (And Illegal) Things

  • Key figure in Mandelson vetting row will not appear to give evidence to MPs

  • ‘Half Man’s Richard Gadd Just Can’t Stop Working: It’s A “Self-Perpetuating Cycle, But I Love It” – Contenders TV

  • Trophyless to treble? Man City’s quest for more history

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube